UCD spin-out developing AI software to predict crystalline states of drug molecules for drug development.
| Date | Round | Amount |
|---|---|---|
| Sep 2021 | Seed UCD spin-out BioSimulytics closed a €595,000 seed round from angel investors and Enterprise Ireland to grow its AI drug-development software. | $670K |